Cargando…

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer

The aim of this study was to explore the male predominance in esophageal and gastric adenocarcinoma by evaluating the preventive potential of androgen deprivation therapy (ADT). This matched cohort study was based on a national Swedish database of prostate cancer patients in 2006–2013. Prostate canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shore, Richard, Yu, Jingru, Ye, Weimin, Lagergren, Jesper, Rutegård, Martin, Akre, Olof, Stattin, Pär, Lindblad, Mats
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241984/ https://www.ncbi.nlm.nih.gov/pubmed/34188067 http://dx.doi.org/10.1038/s41598-021-92347-0

Ejemplares similares

Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study
por: Shore, Richard, et al.
Publicado: (2023)

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic
por: Gedeborg, Rolf, et al.
Publicado: (2021)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Association between Education Level and Prognosis after Esophageal Cancer Surgery: A Swedish Population-Based Cohort Study
por: Brusselaers, Nele, et al.
Publicado: (2015)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
por: Johnson, Matthew E., et al.
Publicado: (2012)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Mortality following Hip Fracture in Men with Prostate Cancer
por: Van Hemelrijck, Mieke, et al.
Publicado: (2013)

Prediabetes and diabetes in relation to risk of gastric adenocarcinoma
por: Zheng, Jiaojiao, et al.
Publicado: (2019)

Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study
por: Hermann, Maria, et al.
Publicado: (2021)

A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012)

A global assessment of the male predominance in esophageal adenocarcinoma
por: Xie, Shao-Hua, et al.
Publicado: (2016)

Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study
por: Wirén, Sara, et al.
Publicado: (2014)

Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study
por: Holmberg, Dag, et al.
Publicado: (2023)

Susceptibility to SARS‐Cov‐2 infection and risk for severe COVID‐19 in patients with prostate cancer on androgen deprivation therapy
por: Gedeborg, Rolf, et al.
Publicado: (2022)

Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma
por: Rutegård, M, et al.
Publicado: (2010)

Lacrimal sac adenocarcinoma managed with androgen deprivation
por: Abramson, David H., et al.
Publicado: (2020)

Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
por: Hirata, Yu, et al.
Publicado: (2019)

Androgen deprivation therapy and excess mortality during the COVID-19 pandemic
por: Stattin, P., et al.
Publicado: (2021)

Lymphadenectomy and risk of reoperation or mortality shortly after surgery for oesophageal cancer
por: Lagergren, Jesper, et al.
Publicado: (2016)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
por: Gongora, Magdalena, et al.
Publicado: (2022)

Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012)

Cardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy?
por: Essien, Okon Ekwere, et al.
Publicado: (2016)

Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
por: Bressi, Barbara, et al.
Publicado: (2020)

The prognostic role of coeliac node metastasis after resection for distal oesophageal cancer
por: Rutegård, Martin, et al.
Publicado: (2017)

ASO Author Reflections: Survival Trends in Gastric Adenocarcinoma
por: Asplund, Johannes, et al.
Publicado: (2018)

Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol
por: Bressi, Barbara, et al.
Publicado: (2022)

Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
por: Lindblad, M, et al.
Publicado: (2006)

Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation
por: Bulbul, Ajaz
Publicado: (2018)

Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
por: Ouyang, Wei, et al.
Publicado: (2021)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
por: Saad, Fred, et al.
Publicado: (2021)

Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy
por: Blow, Tahj A., et al.
Publicado: (2023)

How do we define “castration” in men on androgen deprivation therapy?
por: Itty, Sarin, et al.
Publicado: (2020)

Androgen deprivation and SARS-CoV-2 in men with prostate cancer
por: Koskinen, M., et al.
Publicado: (2020)

Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?
por: Sjödahl, Krister, et al.
Publicado: (2010)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro
por: Palethorpe, Helen M., et al.
Publicado: (2017)

Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review
por: Wilson, Rebekah L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4spl8j3d11fdpts7hsr37qhvi